SAN DIEGO, CA, Oct. 04, 2022 (GLOBE NEWSWIRE) — through NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Firm”), the first-ever publicly traded hashish firm in the USA that launched the world’s first-ever cannabis-derived nutraceutical merchandise, manufacturers, and provide chain, introduced at this time that it has entered into an Asset Buy Settlement with MFINITY International LLC, a direct-selling group centered on selling pure well being and a rewarding gross sales mannequin. Moreover, Invoice Andreoli, the President of MFINITY International will change into the President of Medical Marijuana, Inc. subsidiary, Kannaway, LLC.
The MFINITY product line options Muscadine, a strong antioxidant that gives many wellness advantages. MFINITY merchandise might be marketed and offered solely underneath the Kannaway model and are actually accessible on the market by Kannaway unbiased distributors and on Kannaway.com. The MFINITY gross sales drive, recognized in any other case as Model Ambassadors, will change into Kannaway Model Ambassadors, and can instantly have entry to market and promote the world’s main non-psychoactive, cannabis-based merchandise.
The asset buy aligns with Medical Marijuana Inc.’s newly applied development mannequin of growth through acquisition. The addition of newly appointed Kannaway President, Invoice Andreoli, additional positions the Firm to pursue this technique given Mr. Andreoli’s success in finishing over a dozen acquisitions all through his profession. Medical Marijuana Inc.’s in-house manufacturing and distribution capabilities allow the corporate to simply add formulations and product traces from acquired firms and propel product gross sales by its worldwide platform and world footprint, spanning throughout 4 continents. Medical Marijuana, Inc. is poised for development through this acquisition technique.
“I couldn’t be extra excited to tackle my new function as Kannaway President and lead the corporate and its growth technique,” mentioned Invoice Andreoli, newly appointed President of Kannaway. “Efficiently buying and integrating manufacturers is one thing I’ve carried out with nice success up to now and I stay up for implementing that mannequin right here at Medical Marijuana, Inc.”
“This Settlement units Kannaway on a brand new and thrilling course, addition through acquisition,” mentioned Blake Schroeder, CEO of Medical Marijuana, Inc. “Our Firm is effectively positioned for this mannequin, and we’re keen to construct upon this settlement as a mannequin for the longer term. We’re likewise excited so as to add the MFINITY product line to our portfolio and to welcome the MFINITY model ambassador staff to Kannaway as we consider each will improve our worth.”
ABOUT MEDICAL MARIJUANA, INC.:
We’re an organization of firsts®. Medical Marijuana, Inc. (MJNA) is a hashish firm with three distinct enterprise items within the non-psychoactive cannabinoid house: a world portfolio of cannabinoid-based nutraceutical manufacturers led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality authorized non-psychoactive hashish merchandise derived from industrial hemp; and a cannabinoid-based scientific analysis and botanical drug improvement sector led by its pharmaceutical funding firms and companions together with AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named a prime CBD producer by CNBC. Medical Marijuana, Inc. was additionally the primary firm to obtain historic import permits for CBD merchandise from the governments of Brazil, Mexico, Argentina, and Paraguay and is a frontrunner within the improvement of worldwide markets. The corporate’s flagship product Actual Scientific Hemp Oil has been utilized in a number of profitable scientific research all through Mexico and Brazil to know its security and efficacy.
Medical Marijuana, Inc.’s headquarters is in San Diego, California, and extra info is on the market at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s company video, click on right here.
FORWARD-LOOKING DISCLAIMER:
This press launch could comprise sure forward-looking statements and data, as outlined inside the which means of Part 27A of the Securities Act of 1933 and Part 21E of the Securities Change Act of 1934, and is topic to the Protected Harbor created by these sections. This materials comprises statements about anticipated future occasions and/or monetary outcomes which might be forward-looking in nature and topic to dangers and uncertainties. Such forward-looking statements by definition contain dangers, uncertainties and different elements, which can trigger the precise outcomes, efficiency or achievements of Medical Marijuana, Inc. to be materially totally different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE:
These statements haven’t been evaluated by the Meals and Drug Administration. This product is just not supposed to diagnose, deal with, treatment, or stop any illness.
LEGAL DISCLOSURE:
Medical Marijuana, Inc. doesn’t promote or distribute any merchandise which might be in violation of the USA Managed Substances Act.
CONTACT:
Public Relations Contact:
Kyle Porter
CEO
CMW Media
P. 858-221-8001
[email protected]
www.cmwmedia.com
Investor Relations Contact:
P. (858) 283-4016
[email protected]
